Medical - Devices
Compare Stocks
4 / 10Stock Comparison
ADGM vs ABLV vs BEAT vs AGMH
Revenue, margins, valuation, and 5-year total return — side by side.
Advertising Agencies
Medical - Healthcare Information Services
Software - Application
ADGM vs ABLV vs BEAT vs AGMH — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Medical - Devices | Advertising Agencies | Medical - Healthcare Information Services | Software - Application |
| Market Cap | $15M | $33M | $35M | $437K |
| Revenue (TTM) | $-143K | $113M | $0.00 | $32M |
| Net Income (TTM) | $-75M | $2M | $-21M | $3M |
| Gross Margin | -6.2% | 12.3% | — | 21.4% |
| Operating Margin | -232.3% | 0.6% | — | 18.6% |
| Forward P/E | — | — | — | 0.1x |
| Total Debt | $16M | $11M | $0.00 | $2M |
| Cash & Equiv. | $21M | $15M | $4M | $1M |
ADGM vs ABLV vs BEAT vs AGMH — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Aug 24 | May 26 | Return |
|---|---|---|---|
| Adagio Medical Hold… (ADGM) | 100 | 18.5 | -81.5% |
| Able View Inc. (ABLV) | 100 | 42.9 | -57.1% |
| HeartBeam, Inc. (BEAT) | 100 | 37.0 | -63.0% |
| AGM Group Holdings … (AGMH) | 100 | 1.6 | -98.4% |
Price return only. Dividends and distributions are not included.
Quick Verdict: ADGM vs ABLV vs BEAT vs AGMH
Each card shows where this stock fits in a portfolio — not just who wins on paper.
ADGM carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- beta 0.87
- Rev growth -10.3%, EPS growth 27.2%, 3Y rev CAGR -0.1%
- Lower volatility, beta 0.87, Low D/E 81.7%, current ratio 3.27x
- Beta 0.87, current ratio 3.27x
ABLV is the #2 pick in this set and the best alternative if dividends and efficiency is your priority.
- 0.2% yield; the other 3 pay no meaningful dividend
- 5.4% ROA vs BEAT's -353.1%
BEAT is the clearest fit if your priority is long-term compounding.
- -81.4% 10Y total return vs ABLV's -87.8%
AGMH is the clearest fit if your priority is quality.
- 9.7% margin vs ADGM's -199.9%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | -10.3% revenue growth vs BEAT's -100.0% | |
| Quality / Margins | 9.7% margin vs ADGM's -199.9% | |
| Stability / Safety | Beta 0.87 vs AGMH's 1.68 | |
| Dividends | 0.2% yield; the other 3 pay no meaningful dividend | |
| Momentum (1Y) | -26.1% vs AGMH's -80.1% | |
| Efficiency (ROA) | 5.4% ROA vs BEAT's -353.1% |
ADGM vs ABLV vs BEAT vs AGMH — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
Segment breakdown not available.
ADGM vs ABLV vs BEAT vs AGMH — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
AGMH leads in 3 of 6 categories
BEAT leads 1 • ABLV leads 1 • ADGM leads 0
Explore the data ↓Income & Cash Flow (Last 12 Months)
AGMH leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
ABLV and ADGM operate at a comparable scale, with $113M and -$143,000 in trailing revenue. AGMH is the more profitable business, keeping 9.7% of every revenue dollar as net income compared to ADGM's -199.9%. On growth, ABLV holds the edge at -25.7% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | -$143,000 | $113M | $0 | $32M |
| EBITDAEarnings before interest/tax | -$67M | $902,648 | -$21M | $6M |
| Net IncomeAfter-tax profit | -$75M | $2M | -$21M | $3M |
| Free Cash FlowCash after capex | -$24M | $3M | -$15M | $7M |
| Gross MarginGross profit ÷ Revenue | -6.2% | +12.3% | — | +21.4% |
| Operating MarginEBIT ÷ Revenue | -232.3% | +0.6% | — | +18.6% |
| Net MarginNet income ÷ Revenue | -199.9% | +2.1% | — | +9.7% |
| FCF MarginFCF ÷ Revenue | -115.6% | +2.7% | — | +22.2% |
| Rev. Growth (YoY)Latest quarter vs prior year | -100.0% | -25.7% | — | -49.9% |
| EPS Growth (YoY)Latest quarter vs prior year | -106.3% | +97.8% | +22.2% | +159.2% |
Valuation Metrics
AGMH leads this category, winning 2 of 3 comparable metrics.
Valuation Metrics
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $15M | $33M | $35M | $436,590 |
| Enterprise ValueMkt cap + debt − cash | $10M | $29M | $31M | $1M |
| Trailing P/EPrice ÷ TTM EPS | -0.27x | -3.72x | -1.40x | 0.14x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — | — | — |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — |
| EV / EBITDAEnterprise value multiple | — | — | — | 0.25x |
| Price / SalesMarket cap ÷ Revenue | 54.49x | 0.26x | — | 0.01x |
| Price / BookPrice ÷ Book value/share | 0.73x | 3.95x | 11.27x | 0.02x |
| Price / FCFMarket cap ÷ FCF | — | — | — | 0.06x |
Profitability & Efficiency
AGMH leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
ABLV delivers a 27.9% return on equity — every $100 of shareholder capital generates $28 in annual profit, vs $-8 for ADGM. AGMH carries lower financial leverage with a 0.10x debt-to-equity ratio, signaling a more conservative balance sheet compared to ABLV's 1.57x. On the Piotroski fundamental quality scale (0–9), AGMH scores 8/9 vs BEAT's 1/9, reflecting strong financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | -7.5% | +27.9% | -5.7% | +14.3% |
| ROA (TTM)Return on assets | -189.8% | +5.4% | -3.5% | +5.1% |
| ROICReturn on invested capital | — | -81.3% | — | +17.7% |
| ROCEReturn on capital employed | -374.1% | -25.4% | -4.6% | +28.7% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 2 | 1 | 8 |
| Debt / EquityFinancial leverage | 0.82x | 1.57x | — | 0.10x |
| Net DebtTotal debt minus cash | -$4M | -$4M | -$4M | -$1M |
| Cash & Equiv.Liquid assets | $21M | $15M | $4M | $1M |
| Total DebtShort + long-term debt | $16M | $11M | $0 | $2M |
| Interest CoverageEBIT ÷ Interest expense | -36.69x | -22.79x | — | — |
Total Returns (Dividends Reinvested)
BEAT leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in BEAT five years ago would be worth $1,856 today (with dividends reinvested), compared to $15 for AGMH. Over the past 12 months, ADGM leads with a -26.1% total return vs AGMH's -80.1%. The 3-year compound annual growth rate (CAGR) favors BEAT at -25.8% vs AGMH's -79.8% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | -11.8% | -0.4% | -64.2% | -54.5% |
| 1-Year ReturnPast 12 months | -26.1% | -48.1% | -53.7% | -80.1% |
| 3-Year ReturnCumulative with dividends | -89.5% | -87.8% | -59.1% | -99.2% |
| 5-Year ReturnCumulative with dividends | -89.5% | -87.8% | -81.4% | -99.8% |
| 10-Year ReturnCumulative with dividends | -89.5% | -87.8% | -81.4% | -99.7% |
| CAGR (3Y)Annualised 3-year return | -52.8% | -50.4% | -25.8% | -79.8% |
Risk & Volatility
ABLV leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
ABLV is the less volatile stock with a -0.46 beta — it tends to amplify market swings less than AGMH's 1.68 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. ABLV currently trades 37.9% from its 52-week high vs AGMH's 5.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.87x | -0.46x | 1.24x | 1.68x |
| 52-Week HighHighest price in past year | $2.58 | $1.77 | $4.00 | $18.10 |
| 52-Week LowLowest price in past year | $0.74 | $0.54 | $0.54 | $0.77 |
| % of 52W HighCurrent price vs 52-week peak | +36.9% | +37.9% | +21.8% | +5.0% |
| RSI (14)Momentum oscillator 0–100 | 37.3 | 51.4 | 37.3 | 43.8 |
| Avg Volume (50D)Average daily shares traded | 124K | 314K | 1.6M | 84K |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
ABLV is the only dividend payer here at 0.21% yield — a key consideration for income-focused portfolios.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | — | — | — |
| Price TargetConsensus 12-month target | — | — | — | — |
| # AnalystsCovering analysts | — | — | — | — |
| Dividend YieldAnnual dividend ÷ price | — | +0.2% | — | — |
| Dividend StreakConsecutive years of raises | — | 0 | — | — |
| Dividend / ShareAnnual DPS | — | $0.00 | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +2.6% | 0.0% | 0.0% |
AGMH leads in 3 of 6 categories (Income & Cash Flow, Valuation Metrics). BEAT leads in 1 (Total Returns).
ADGM vs ABLV vs BEAT vs AGMH: Key Questions Answered
8 questions · data-driven answers · updated daily
01Is ADGM or ABLV or BEAT or AGMH a better buy right now?
For growth investors, Adagio Medical Holdings, Inc.
(ADGM) is the stronger pick with -10. 3% revenue growth year-over-year, versus -65. 5% for AGM Group Holdings Inc. (AGMH). AGM Group Holdings Inc. (AGMH) offers the better valuation at 0. 1x trailing P/E, making it the more compelling value choice. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — ADGM or ABLV or BEAT or AGMH?
Over the past 5 years, HeartBeam, Inc.
(BEAT) delivered a total return of -81. 4%, compared to -99. 8% for AGM Group Holdings Inc. (AGMH). Over 10 years, the gap is even starker: BEAT returned -81. 4% versus AGMH's -99. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — ADGM or ABLV or BEAT or AGMH?
By beta (market sensitivity over 5 years), Able View Inc.
(ABLV) is the lower-risk stock at -0. 46β versus AGM Group Holdings Inc. 's 1. 68β — meaning AGMH is approximately -468% more volatile than ABLV relative to the S&P 500. On balance sheet safety, AGM Group Holdings Inc. (AGMH) carries a lower debt/equity ratio of 10% versus 157% for Able View Inc. — giving it more financial flexibility in a downturn.
04Which is growing faster — ADGM or ABLV or BEAT or AGMH?
By revenue growth (latest reported year), Adagio Medical Holdings, Inc.
(ADGM) is pulling ahead at -10. 3% versus -65. 5% for AGM Group Holdings Inc. (AGMH). On earnings-per-share growth, the picture is similar: AGM Group Holdings Inc. grew EPS 141. 9% year-over-year, compared to -175. 0% for Able View Inc.. Over a 3-year CAGR, ABLV leads at 3. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — ADGM or ABLV or BEAT or AGMH?
AGM Group Holdings Inc.
(AGMH) is the more profitable company, earning 9. 7% net margin versus -199. 9% for Adagio Medical Holdings, Inc. — meaning it keeps 9. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: AGMH leads at 18. 6% versus -232. 3% for ADGM. At the gross margin level — before operating expenses — AGMH leads at 21. 4%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Which pays a better dividend — ADGM or ABLV or BEAT or AGMH?
In this comparison, ABLV (0.
2% yield) pays a dividend. ADGM, BEAT, AGMH do not pay a meaningful dividend and should not be held primarily for income.
07Is ADGM or ABLV or BEAT or AGMH better for a retirement portfolio?
For long-horizon retirement investors, Able View Inc.
(ABLV) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0. 46)). AGM Group Holdings Inc. (AGMH) carries a higher beta of 1. 68 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (ABLV: -87. 8%, AGMH: -99. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
08What are the main differences between ADGM and ABLV and BEAT and AGMH?
These companies operate in different sectors (ADGM (Healthcare) and ABLV (Communication Services) and BEAT (Healthcare) and AGMH (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: ADGM is a small-cap quality compounder stock; ABLV is a small-cap quality compounder stock; BEAT is a small-cap quality compounder stock; AGMH is a small-cap deep-value stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.